Search

Search Constraints

You searched for: Author/Creator Castellví, Ivan

Search Results

1. AB0319 ABATACEPT IN RHEUMATOID ARTHRITIS WITH INTERSTITIAL LUNG DISEASE. A MULTICENTRE STUDY OF 181 PATIENTS. (June 2019)

2. AB0511 A COMPARATIVE STUDY ON CLINICAL AND SEROLOGICAL CHARACTERISTICS BETWEEN PATIENTS WITH RHUPUS AND PATIENTS WITH SYSTEMIC LUPUS ERYTHEMATOSUS. (June 2019)

3. AB0586 TAKAYASU ARTERITIS: REVIEW OF DIAGNOSTIC AND CLASSIFICATION CRITERIA IN A 9 CASE SERIES. (June 2019)

4. AB0671 DISCORDANCE IN ANTI-TIF-1γ ANTIBODIES DETECTION THROUGH COMMERCIAL KIT IN COMPARISON WITH HOMEMADE IMMUNOBLOT: CLINICAL EVALUATION. (June 2019)

5. AB1271 DESCRIPTION OF A COHORT OF PATIENTS WITH SYSTEMIC SCLEROSIS AND ANTINEUTROPHIL CYTOPLASMIC ANTIBODIES (ANCA). (June 2019)

6. Confirmation of TNIP1 but not RHOB and PSORS1C1 as systemic sclerosis risk factors in a large independent replication study. Issue 4 (15th August 2012)

7. Effectiveness and safety of tocilizumab for the treatment of refractory systemic sclerosis associated interstitial lung disease: a case series. Issue 11 (23rd October 2018)

8. Effectiveness and safety of tocilizumab for the treatment of refractory systemic sclerosis associated interstitial lung disease: a case series. Issue 11 (November 2019)

9. Effectiveness and safety of tocilizumab in patients with systemic sclerosis: a propensity score matched controlled observational study of the EUSTAR cohort. Issue 2 (3rd November 2022)

10. FRI0270 APREMILAST IN NON-ULCER MANIFESTATIONS IN BEHçET'S DISEASE. MULTICENTER STUDY OF 32 CASES IN CLINICAL PRACTICE. (June 2019)